Pharmacology of New Sleep-Improving Drugs

  • J. M. Stutzmann
  • P. M. Laduron
  • J. C. Blanchard
Conference paper

Abstract

Our modern way of life with its high levels of stress and anxiety has increased the salience of problems associated with insomnia and consequently also the search for drugs to alleviate this symptom. This review presents the most recent pharmacological data on two types of new sleep-improving drugs: (a) new hypnotics, which have proven active in humans, and (b) sleep modulators, which represent a speculative but interesting approach to the treatment of sleep disorders. We describe here compounds representative of each in terms of pharmacological profile and biochemical characteristics.

Keywords

Dopamine Adenosine Caffeine Diazepam Midazolam 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bénavides J, Camelin JC, Mitrani N, Flamand F, Uzan A, Legrand JJ, Gueremy C, Le Fur G (1985) 2-amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. II. Neuropharmacology 24: 1085–1092PubMedCrossRefGoogle Scholar
  2. Billiard M, Besset A, De Lustrac C, Brissand L (1987) Dose-response effects of zopiclone on night sleep and on nightime and daytime functioning. Sleep 10 (suppl) 1: 27–34Google Scholar
  3. Blagoeva P, Masi I, Scotti de Carolis A, Longo VG (1972) Amino acid release from the cerebral cortex of the rabbit, its relationship with the electrocorticogram. Physiol Behav 9: 307–313PubMedCrossRefGoogle Scholar
  4. Blanchard JC, Stutzmann JM (1988) Zopiclone (imovane) un nouvel hypnotique non benzodiazepinique: propriétés pharmacologiques et mecanisme d’action. Rev sci Méd 2: 65–81Google Scholar
  5. Blanchard JC, Boireaua, Garret C, Julou L (1979) In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci 24: 2417–2420PubMedCrossRefGoogle Scholar
  6. Blanchard JC, Boireau A, Julou L (1983 a) Brain receptors and zopiclone. Pharmacology 27 (Suppl) 2: 59–69CrossRefGoogle Scholar
  7. Blanchard JC, Zundel JL, Julou L (1983 b) Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepines binding to rat hippocampus photolabelled membranes. Biochem Pharmacol 32: 3651–3653CrossRefGoogle Scholar
  8. Braestrup C, Nielsen M (1981) [3H]Propyl β-carboline-3-carboxylate as a selective radioligand for the BZD1 benzodiazepine receptor subclass. J Neurochem 37: 333–341Google Scholar
  9. Chéramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitory or inhibitory influence of L-glutamate. Neuroscience 19: 1081–1090PubMedCrossRefGoogle Scholar
  10. Cook L, Davidson AB (1973) Effects of behaviourally active drugs in a conflict punishment procedure in rats. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 327–345Google Scholar
  11. Declerck AC, Wauquier PHM, Van der Ham-Veltman, Gelders Y (1987) Increase of slow wave sleep in human volunteers by the serotonin S2 2 2 2 2 2 2 antagonist ritanserin. Curr Ther Res 41: 427–432Google Scholar
  12. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237: 649–658PubMedGoogle Scholar
  13. Depoortere H, Decobert M, Riou-Merle F, Granger P (1988) Pharmaco-EEG profile of Zolpidem: an imidazopyridine hypnotic agent. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven, New York, pp 81–96Google Scholar
  14. Disbrow JK, Ruth J A (1984) Differential glutamate release in brain regions of long sleep and short sleep mice. Alcohol 1: 201–203PubMedCrossRefGoogle Scholar
  15. Doble A, Hubert JP, Perrier ML (1987) The pharmacology of an excitatory amino acid receptor. Br J Pharmacol 91: 23Google Scholar
  16. Dugovic C, Wauquier A (1987) 5-HT2 receptors could be primarily involved in the regulation of slow wave sleep in the rat. Eur J Pharmacol 137: 145–146Google Scholar
  17. Geller I, Seifter J (1960) The effects of meprobamate, barbiturates D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacology 1: 482–492CrossRefGoogle Scholar
  18. Hollister LE (1973) Antianxiety drugs in clinical practice. In: Garettini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 367–377Google Scholar
  19. Idzikowski C, Mills FJ, Glennard R (1986) 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res 378: 164–168Google Scholar
  20. Janssen PAJ (1988) The relevance of pharmacological studies to sleep research in psychiatry. Pharmacopsychiatry 21: 33–37PubMedCrossRefGoogle Scholar
  21. Jasper H, Koyama I (1969) Rate of release of amino acids from the cerebral cortex in the cat affected by brainstem and thalamic stimulation. Can J Physiol Pharmacol 47: 889–905PubMedCrossRefGoogle Scholar
  22. Jouvet M (1983) Mecanismes des etats de sommeil. In: Benoit O (ed) Physiologie du sommeil. Masson, Paris, pp 1–18Google Scholar
  23. Julou L, Bardone MC, Blanchard JC, Garret C, Stutzmann JM (1983) Pharmacological studies on zopiclone. Pharmacology 27: 46–58PubMedCrossRefGoogle Scholar
  24. Julou L, Blanchard JC, Dreyfus JF (1985) Pharmacological and clinical studies of cy-clopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav 23: 653–659PubMedCrossRefGoogle Scholar
  25. Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B (1979) Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 11: 457–462PubMedCrossRefGoogle Scholar
  26. Langer SZ, Arbilla S (1988) Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes. Fundam Clin Pharmacol 2: 159–170PubMedCrossRefGoogle Scholar
  27. Langer SZ, Depoortere H, Sanger D, George P, Zivkovic B, Arbilla S, Lloyd KG, Bartholini G (1985) Biochemical and pharmacological profile of SL 80.0759–23 N, a new short acting hypnotic. J Neurochem 44: S179Google Scholar
  28. Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron P (1985) Receptor-binding properties in vitro and in vivo of ritanserin. Mol Pharmacol 27: 600–611PubMedGoogle Scholar
  29. Lippa AS, Jackson D, Wennogle LP, Beer B, Meyerson LR (1982) Non-benzodiazepine antagonists for benzodiazepine receptors. In: Usdin E, Skolnick P, Tallman JF, Greenblett D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan Press, London, pp 431 - 440Google Scholar
  30. Marks J (1980) The benzodiazepine use and abuse. Arzneimittelforschung/Drug Res 30: 388–390Google Scholar
  31. Michel F, Klein M, Jouvet D, Valatx JL (1961) Etude polygraphique du sommeil chez le rat. C R Soc Biol (Paris) 155: 2389–2392Google Scholar
  32. Mizoule J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A, Legrand JJ, Guérémy C, Le Fur G (1985) 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. I. Anticonvulsant properties. Neuropharmacology 24: 767–773PubMedCrossRefGoogle Scholar
  33. Möhler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849–851PubMedCrossRefGoogle Scholar
  34. Rataud J, Bardone MC, Stutzmann JM, Mazadier M, Uzan A, Blanchard JC, Laduron P (1988) Riluzole (PK 26124) induces discriminative stimuli in rats. Psychopharmacology 96 (Suppl): 373Google Scholar
  35. Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD (1983) Adenosine analogs and sleep in rats. J Pharmacol Exp Ther 228: 268–274Google Scholar
  36. Scatton B, Claustre Y, Dennis T, Nishikawa T (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines. J Pharmacol Exp Ther 237: 659–665PubMedGoogle Scholar
  37. Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez M, Rhee LM, Ramachadran J, Reale V, Glencorse TA, Seeburg PH, Barnard EA (1987) Sequence and functional expression of the GABAa receptor shows a ligand-gated receptor super-family. Nature 328: 221–227PubMedCrossRefGoogle Scholar
  38. Snyder SH (1987) GABA-benzodiazepine receptor complex: focus on receptor subtypes and Cyclopyrrolone drugs. Isr J Med Sci 23: 145–152PubMedGoogle Scholar
  39. Squires RF, Braestrup C (1977) Benzodiazepine receptor in rat brain. Nature 266: 732–734PubMedCrossRefGoogle Scholar
  40. Stutzmann JM, Lucas M, Blanchard JC, Laduron PM (1988 a) Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats. Neurosci Lett 88: 195–200PubMedCrossRefGoogle Scholar
  41. Stutzmann JM, Laduron PM, Blanchard JC ( 1988 b) Sleep enhancing effect of riluzole in rats and cats. 9th European congress of sleep research, Jérusalem, Abstracts, p 207Google Scholar
  42. Zivkovic B, Perrault G, Morel E, Sanger DJ (1988) Comparative pharmacology of Zolpidem and other hypnotics and sleep inducers. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders. Raven, New York, pp 97–110Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • J. M. Stutzmann
  • P. M. Laduron
  • J. C. Blanchard
    • 1
  1. 1.Centre de Recherches de VitryRhône Poulenc SantéVitry CedexFrance

Personalised recommendations